📰 Risk Evaluation News
Page 5 - Risk Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.
March 26, 2024
The FDA's handling of safety data for mifepristone highlights the need for comprehensive adverse event collection to protect women's health.
March 25, 2024
Analysis from a 10-month post-launch evaluation of the REMS Program finds 2.8% incidence of LVEF ...
March 25, 2024
Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet
March 12, 2024
An Arkansas law prohibiting drugmakers from refusing to supply discounted drugs to certain pharmacies is constitutional, a federal appeals court ruled Tuesday.
March 11, 2024
An expert cardiologist discusses the importance of healthcare provider education and finding resources around the REMS program.
March 11, 2024
Check out this case study to learn more about how viral infections might play a role in triggering psychotic disorders.
March 11, 2024
James L. Januzzi, MD, comments on mavacamten as the first approved cardiac myosin inhibitor for oHCM, balancing the increased risk of heart failure with the medication, and the role of the REMS program.
February 28, 2024
A tool that estimates mortality risk could help clinicians determine which patients receiving home care are close to death and might benefit from palliative care.